nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCC1—Mitoxantrone—multiple sclerosis	0.101	0.126	CbGbCtD
Erythromycin—SLCO1A2—Prednisolone—multiple sclerosis	0.0791	0.099	CbGbCtD
Erythromycin—SLCO1A2—Prednisone—multiple sclerosis	0.0747	0.0935	CbGbCtD
Erythromycin—SLC22A7—Methotrexate—multiple sclerosis	0.0535	0.0669	CbGbCtD
Erythromycin—SLCO1A2—Dexamethasone—multiple sclerosis	0.0467	0.0584	CbGbCtD
Erythromycin—ABCC1—Methotrexate—multiple sclerosis	0.042	0.0525	CbGbCtD
Erythromycin—SLCO1A2—Methotrexate—multiple sclerosis	0.0375	0.0469	CbGbCtD
Erythromycin—ABCB1—Methylprednisolone—multiple sclerosis	0.0333	0.0417	CbGbCtD
Erythromycin—CYP3A4—Fingolimod—multiple sclerosis	0.031	0.0388	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0258	0.0323	CbGbCtD
Erythromycin—CYP3A7—Dexamethasone—multiple sclerosis	0.0258	0.0323	CbGbCtD
Erythromycin—CYP2B6—Dexamethasone—multiple sclerosis	0.0246	0.0308	CbGbCtD
Erythromycin—ABCB1—Mitoxantrone—multiple sclerosis	0.0243	0.0304	CbGbCtD
Erythromycin—ABCB1—Betamethasone—multiple sclerosis	0.0217	0.0271	CbGbCtD
Erythromycin—ABCB1—Prednisolone—multiple sclerosis	0.0214	0.0268	CbGbCtD
Erythromycin—ABCB1—Prednisone—multiple sclerosis	0.0202	0.0253	CbGbCtD
Erythromycin—CYP3A4—Methylprednisolone—multiple sclerosis	0.02	0.025	CbGbCtD
Erythromycin—CYP3A5—Dexamethasone—multiple sclerosis	0.0194	0.0242	CbGbCtD
Erythromycin—CYP3A4—Triamcinolone—multiple sclerosis	0.0151	0.0189	CbGbCtD
Erythromycin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0146	0.0182	CbGbCtD
Erythromycin—CYP3A4—Betamethasone—multiple sclerosis	0.013	0.0162	CbGbCtD
Erythromycin—CYP3A4—Prednisolone—multiple sclerosis	0.0128	0.016	CbGbCtD
Erythromycin—ABCB1—Dexamethasone—multiple sclerosis	0.0126	0.0158	CbGbCtD
Erythromycin—CYP3A4—Prednisone—multiple sclerosis	0.0121	0.0151	CbGbCtD
Erythromycin—ABCB1—Methotrexate—multiple sclerosis	0.0101	0.0127	CbGbCtD
Erythromycin—CYP3A4—Dexamethasone—multiple sclerosis	0.00755	0.00945	CbGbCtD
Erythromycin—Pain of skin—Cladribine—multiple sclerosis	0.00678	0.0649	CcSEcCtD
Erythromycin—Localized exfoliation—Triamcinolone—multiple sclerosis	0.00294	0.0282	CcSEcCtD
Erythromycin—Redness—Cladribine—multiple sclerosis	0.00237	0.0227	CcSEcCtD
Erythromycin—Liver function test abnormal—Fingolimod—multiple sclerosis	0.00189	0.0181	CcSEcCtD
Erythromycin—Trauma—Prednisolone—multiple sclerosis	0.00181	0.0173	CcSEcCtD
Erythromycin—Hepatotoxicity—Azathioprine—multiple sclerosis	0.00168	0.0161	CcSEcCtD
Erythromycin—Trauma—Triamcinolone—multiple sclerosis	0.00166	0.0159	CcSEcCtD
Erythromycin—Trauma—Methylprednisolone—multiple sclerosis	0.00166	0.0159	CcSEcCtD
Erythromycin—Trauma—Betamethasone—multiple sclerosis	0.00151	0.0145	CcSEcCtD
Erythromycin—Trauma—Dexamethasone—multiple sclerosis	0.00151	0.0145	CcSEcCtD
Erythromycin—Trauma—Prednisone—multiple sclerosis	0.00131	0.0126	CcSEcCtD
Erythromycin—Palpitations—Fingolimod—multiple sclerosis	0.00109	0.0104	CcSEcCtD
Erythromycin—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.00108	0.0103	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.00104	0.01	CcSEcCtD
Erythromycin—Eye irritation—Prednisolone—multiple sclerosis	0.00101	0.00966	CcSEcCtD
Erythromycin—Abdominal discomfort—Cladribine—multiple sclerosis	0.000961	0.0092	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.000886	0.00848	CcSEcCtD
Erythromycin—Eruption—Methotrexate—multiple sclerosis	0.00085	0.00814	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.000849	0.00813	CcSEcCtD
Erythromycin—Pancreatitis—Azathioprine—multiple sclerosis	0.000799	0.00765	CcSEcCtD
Erythromycin—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000781	0.00748	CcSEcCtD
Erythromycin—Erythema multiforme—Cladribine—multiple sclerosis	0.000758	0.00726	CcSEcCtD
Erythromycin—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000756	0.00724	CcSEcCtD
Erythromycin—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000755	0.00723	CcSEcCtD
Erythromycin—Burning sensation—Methotrexate—multiple sclerosis	0.000753	0.00721	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00072	0.0069	CcSEcCtD
Erythromycin—Arrhythmia—Cladribine—multiple sclerosis	0.000717	0.00686	CcSEcCtD
Erythromycin—Pruritus—Fingolimod—multiple sclerosis	0.000711	0.00681	CcSEcCtD
Erythromycin—Erythema—Cladribine—multiple sclerosis	0.000698	0.00669	CcSEcCtD
Erythromycin—Diarrhoea—Fingolimod—multiple sclerosis	0.000688	0.00659	CcSEcCtD
Erythromycin—Skin exfoliation—Betamethasone—multiple sclerosis	0.000686	0.00657	CcSEcCtD
Erythromycin—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000686	0.00657	CcSEcCtD
Erythromycin—Injury—Prednisolone—multiple sclerosis	0.00068	0.00651	CcSEcCtD
Erythromycin—Hepatotoxicity—Methotrexate—multiple sclerosis	0.000677	0.00649	CcSEcCtD
Erythromycin—Dizziness—Fingolimod—multiple sclerosis	0.000665	0.00637	CcSEcCtD
Erythromycin—Injury—Triamcinolone—multiple sclerosis	0.000626	0.00599	CcSEcCtD
Erythromycin—Injury—Methylprednisolone—multiple sclerosis	0.000624	0.00598	CcSEcCtD
Erythromycin—Erythema multiforme—Azathioprine—multiple sclerosis	0.000617	0.0059	CcSEcCtD
Erythromycin—Skin exfoliation—Prednisone—multiple sclerosis	0.000598	0.00572	CcSEcCtD
Erythromycin—Chest pain—Cladribine—multiple sclerosis	0.000594	0.00569	CcSEcCtD
Erythromycin—Discomfort—Cladribine—multiple sclerosis	0.000587	0.00562	CcSEcCtD
Erythromycin—Arrhythmia—Azathioprine—multiple sclerosis	0.000583	0.00558	CcSEcCtD
Erythromycin—Confusional state—Cladribine—multiple sclerosis	0.000575	0.0055	CcSEcCtD
Erythromycin—Jaundice—Mitoxantrone—multiple sclerosis	0.000572	0.00548	CcSEcCtD
Erythromycin—Injury—Betamethasone—multiple sclerosis	0.000568	0.00544	CcSEcCtD
Erythromycin—Injury—Dexamethasone—multiple sclerosis	0.000568	0.00544	CcSEcCtD
Erythromycin—Irritability—Methylprednisolone—multiple sclerosis	0.000548	0.00524	CcSEcCtD
Erythromycin—Anorexia—Cladribine—multiple sclerosis	0.000543	0.0052	CcSEcCtD
Erythromycin—Pancreatitis—Prednisolone—multiple sclerosis	0.00053	0.00507	CcSEcCtD
Erythromycin—Hepatitis—Mitoxantrone—multiple sclerosis	0.000527	0.00505	CcSEcCtD
Erythromycin—Skin exfoliation—Methotrexate—multiple sclerosis	0.000499	0.00478	CcSEcCtD
Erythromycin—Irritability—Dexamethasone—multiple sclerosis	0.000498	0.00477	CcSEcCtD
Erythromycin—Irritability—Betamethasone—multiple sclerosis	0.000498	0.00477	CcSEcCtD
Erythromycin—Decreased appetite—Cladribine—multiple sclerosis	0.000495	0.00474	CcSEcCtD
Erythromycin—Injury—Prednisone—multiple sclerosis	0.000494	0.00473	CcSEcCtD
Erythromycin—Pain—Cladribine—multiple sclerosis	0.000487	0.00467	CcSEcCtD
Erythromycin—Pancreatitis—Triamcinolone—multiple sclerosis	0.000487	0.00467	CcSEcCtD
Erythromycin—Pancreatitis—Methylprednisolone—multiple sclerosis	0.000486	0.00466	CcSEcCtD
Erythromycin—Discomfort—Azathioprine—multiple sclerosis	0.000478	0.00457	CcSEcCtD
Erythromycin—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000471	0.00451	CcSEcCtD
Erythromycin—Feeling abnormal—Cladribine—multiple sclerosis	0.00047	0.0045	CcSEcCtD
Erythromycin—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000466	0.00446	CcSEcCtD
Erythromycin—Erythema—Mitoxantrone—multiple sclerosis	0.000459	0.00439	CcSEcCtD
Erythromycin—Urticaria—Cladribine—multiple sclerosis	0.000453	0.00434	CcSEcCtD
Erythromycin—Abdominal pain—Cladribine—multiple sclerosis	0.00045	0.00431	CcSEcCtD
Erythromycin—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000449	0.0043	CcSEcCtD
Erythromycin—Irritability—Prednisone—multiple sclerosis	0.000434	0.00415	CcSEcCtD
Erythromycin—Hypersensitivity—Cladribine—multiple sclerosis	0.00042	0.00402	CcSEcCtD
Erythromycin—Pruritus—Cladribine—multiple sclerosis	0.000403	0.00386	CcSEcCtD
Erythromycin—Convulsion—Mitoxantrone—multiple sclerosis	0.000398	0.00381	CcSEcCtD
Erythromycin—Hallucination—Methylprednisolone—multiple sclerosis	0.000395	0.00378	CcSEcCtD
Erythromycin—Chest pain—Mitoxantrone—multiple sclerosis	0.000391	0.00374	CcSEcCtD
Erythromycin—Diarrhoea—Cladribine—multiple sclerosis	0.00039	0.00373	CcSEcCtD
Erythromycin—Arrhythmia—Prednisolone—multiple sclerosis	0.000386	0.0037	CcSEcCtD
Erythromycin—Discomfort—Mitoxantrone—multiple sclerosis	0.000386	0.0037	CcSEcCtD
Erythromycin—Pancreatitis—Prednisone—multiple sclerosis	0.000385	0.00369	CcSEcCtD
Erythromycin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000382	0.00366	CcSEcCtD
Erythromycin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000379	0.00363	CcSEcCtD
Erythromycin—Confusional state—Mitoxantrone—multiple sclerosis	0.000378	0.00362	CcSEcCtD
Erythromycin—Dizziness—Cladribine—multiple sclerosis	0.000377	0.00361	CcSEcCtD
Erythromycin—Erythema—Prednisolone—multiple sclerosis	0.000377	0.00361	CcSEcCtD
Erythromycin—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000375	0.00359	CcSEcCtD
Erythromycin—Abdominal pain—Azathioprine—multiple sclerosis	0.000366	0.00351	CcSEcCtD
Erythromycin—Irritability—Methotrexate—multiple sclerosis	0.000362	0.00347	CcSEcCtD
Erythromycin—Vomiting—Cladribine—multiple sclerosis	0.000362	0.00347	CcSEcCtD
Erythromycin—Rash—Cladribine—multiple sclerosis	0.000359	0.00344	CcSEcCtD
Erythromycin—Hallucination—Dexamethasone—multiple sclerosis	0.000359	0.00344	CcSEcCtD
Erythromycin—Hallucination—Betamethasone—multiple sclerosis	0.000359	0.00344	CcSEcCtD
Erythromycin—Anorexia—Mitoxantrone—multiple sclerosis	0.000357	0.00342	CcSEcCtD
Erythromycin—Arrhythmia—Triamcinolone—multiple sclerosis	0.000355	0.0034	CcSEcCtD
Erythromycin—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000355	0.0034	CcSEcCtD
Erythromycin—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000351	0.00336	CcSEcCtD
Erythromycin—Erythema—Triamcinolone—multiple sclerosis	0.000346	0.00332	CcSEcCtD
Erythromycin—Erythema—Methylprednisolone—multiple sclerosis	0.000345	0.00331	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000342	0.00327	CcSEcCtD
Erythromycin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000341	0.00327	CcSEcCtD
Erythromycin—Dysgeusia—Triamcinolone—multiple sclerosis	0.000339	0.00325	CcSEcCtD
Erythromycin—Nausea—Cladribine—multiple sclerosis	0.000338	0.00324	CcSEcCtD
Erythromycin—Vertigo—Prednisolone—multiple sclerosis	0.000338	0.00324	CcSEcCtD
Erythromycin—Convulsion—Prednisolone—multiple sclerosis	0.000326	0.00312	CcSEcCtD
Erythromycin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000326	0.00312	CcSEcCtD
Erythromycin—Arrhythmia—Betamethasone—multiple sclerosis	0.000322	0.00309	CcSEcCtD
Erythromycin—Arrhythmia—Dexamethasone—multiple sclerosis	0.000322	0.00309	CcSEcCtD
Erythromycin—Pancreatitis—Methotrexate—multiple sclerosis	0.000322	0.00308	CcSEcCtD
Erythromycin—Pain—Mitoxantrone—multiple sclerosis	0.00032	0.00307	CcSEcCtD
Erythromycin—Diarrhoea—Azathioprine—multiple sclerosis	0.000317	0.00304	CcSEcCtD
Erythromycin—Discomfort—Prednisolone—multiple sclerosis	0.000317	0.00303	CcSEcCtD
Erythromycin—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000315	0.00301	CcSEcCtD
Erythromycin—Erythema—Betamethasone—multiple sclerosis	0.000314	0.00301	CcSEcCtD
Erythromycin—Erythema—Dexamethasone—multiple sclerosis	0.000314	0.00301	CcSEcCtD
Erythromycin—Hallucination—Prednisone—multiple sclerosis	0.000313	0.00299	CcSEcCtD
Erythromycin—Vertigo—Triamcinolone—multiple sclerosis	0.000311	0.00298	CcSEcCtD
Erythromycin—Vertigo—Methylprednisolone—multiple sclerosis	0.00031	0.00297	CcSEcCtD
Erythromycin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000309	0.00296	CcSEcCtD
Erythromycin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000307	0.00294	CcSEcCtD
Erythromycin—Dizziness—Azathioprine—multiple sclerosis	0.000306	0.00293	CcSEcCtD
Erythromycin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000306	0.00293	CcSEcCtD
Erythromycin—Convulsion—Triamcinolone—multiple sclerosis	0.0003	0.00287	CcSEcCtD
Erythromycin—Convulsion—Methylprednisolone—multiple sclerosis	0.000299	0.00287	CcSEcCtD
Erythromycin—Urticaria—Mitoxantrone—multiple sclerosis	0.000298	0.00285	CcSEcCtD
Erythromycin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000296	0.00284	CcSEcCtD
Erythromycin—Vomiting—Azathioprine—multiple sclerosis	0.000295	0.00282	CcSEcCtD
Erythromycin—Rash—Azathioprine—multiple sclerosis	0.000292	0.0028	CcSEcCtD
Erythromycin—Discomfort—Triamcinolone—multiple sclerosis	0.000291	0.00279	CcSEcCtD
Erythromycin—Discomfort—Methylprednisolone—multiple sclerosis	0.000291	0.00278	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00029	0.00278	CcSEcCtD
Erythromycin—Confusional state—Methylprednisolone—multiple sclerosis	0.000284	0.00272	CcSEcCtD
Erythromycin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000283	0.00271	CcSEcCtD
Erythromycin—Vertigo—Dexamethasone—multiple sclerosis	0.000282	0.0027	CcSEcCtD
Erythromycin—Vertigo—Betamethasone—multiple sclerosis	0.000282	0.0027	CcSEcCtD
Erythromycin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000282	0.0027	CcSEcCtD
Erythromycin—Arrhythmia—Prednisone—multiple sclerosis	0.000281	0.00269	CcSEcCtD
Erythromycin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000276	0.00264	CcSEcCtD
Erythromycin—Nausea—Azathioprine—multiple sclerosis	0.000275	0.00264	CcSEcCtD
Erythromycin—Erythema—Prednisone—multiple sclerosis	0.000274	0.00262	CcSEcCtD
Erythromycin—Convulsion—Dexamethasone—multiple sclerosis	0.000272	0.00261	CcSEcCtD
Erythromycin—Convulsion—Betamethasone—multiple sclerosis	0.000272	0.00261	CcSEcCtD
Erythromycin—Discomfort—Dexamethasone—multiple sclerosis	0.000264	0.00253	CcSEcCtD
Erythromycin—Discomfort—Betamethasone—multiple sclerosis	0.000264	0.00253	CcSEcCtD
Erythromycin—Pain—Prednisolone—multiple sclerosis	0.000263	0.00252	CcSEcCtD
Erythromycin—Hepatitis—Methotrexate—multiple sclerosis	0.000263	0.00252	CcSEcCtD
Erythromycin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000256	0.00246	CcSEcCtD
Erythromycin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000256	0.00246	CcSEcCtD
Erythromycin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000256	0.00245	CcSEcCtD
Erythromycin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000253	0.00242	CcSEcCtD
Erythromycin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000248	0.00238	CcSEcCtD
Erythromycin—Vertigo—Prednisone—multiple sclerosis	0.000246	0.00235	CcSEcCtD
Erythromycin—Tinnitus—Methotrexate—multiple sclerosis	0.000245	0.00235	CcSEcCtD
Erythromycin—Anorexia—Dexamethasone—multiple sclerosis	0.000244	0.00234	CcSEcCtD
Erythromycin—Anorexia—Betamethasone—multiple sclerosis	0.000244	0.00234	CcSEcCtD
Erythromycin—Urticaria—Prednisolone—multiple sclerosis	0.000244	0.00234	CcSEcCtD
Erythromycin—Pain—Triamcinolone—multiple sclerosis	0.000242	0.00231	CcSEcCtD
Erythromycin—Vomiting—Mitoxantrone—multiple sclerosis	0.000238	0.00228	CcSEcCtD
Erythromycin—Convulsion—Prednisone—multiple sclerosis	0.000237	0.00227	CcSEcCtD
Erythromycin—Rash—Mitoxantrone—multiple sclerosis	0.000236	0.00226	CcSEcCtD
Erythromycin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000233	0.00223	CcSEcCtD
Erythromycin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000232	0.00223	CcSEcCtD
Erythromycin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000231	0.00221	CcSEcCtD
Erythromycin—Discomfort—Prednisone—multiple sclerosis	0.00023	0.0022	CcSEcCtD
Erythromycin—Erythema—Methotrexate—multiple sclerosis	0.000229	0.00219	CcSEcCtD
Erythromycin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000226	0.00217	CcSEcCtD
Erythromycin—Urticaria—Triamcinolone—multiple sclerosis	0.000224	0.00215	CcSEcCtD
Erythromycin—Urticaria—Methylprednisolone—multiple sclerosis	0.000224	0.00214	CcSEcCtD
Erythromycin—Dysgeusia—Methotrexate—multiple sclerosis	0.000224	0.00214	CcSEcCtD
Erythromycin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000223	0.00214	CcSEcCtD
Erythromycin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000223	0.00213	CcSEcCtD
Erythromycin—Decreased appetite—Betamethasone—multiple sclerosis	0.000223	0.00213	CcSEcCtD
Erythromycin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000223	0.00213	CcSEcCtD
Erythromycin—Nausea—Mitoxantrone—multiple sclerosis	0.000222	0.00213	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCR2—multiple sclerosis	0.000221	0.0023	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.00022	0.00229	CbGpPWpGaD
Erythromycin—Pain—Betamethasone—multiple sclerosis	0.000219	0.0021	CcSEcCtD
Erythromycin—Pain—Dexamethasone—multiple sclerosis	0.000219	0.0021	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000218	0.00226	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000217	0.00226	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000217	0.00226	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—POMC—multiple sclerosis	0.000217	0.00225	CbGpPWpGaD
Erythromycin—Anorexia—Prednisone—multiple sclerosis	0.000213	0.00204	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCL2—multiple sclerosis	0.000212	0.00221	CbGpPWpGaD
Erythromycin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000211	0.00202	CcSEcCtD
Erythromycin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000211	0.00202	CcSEcCtD
Erythromycin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00021	0.00201	CcSEcCtD
Erythromycin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00021	0.00201	CcSEcCtD
Erythromycin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000208	0.00199	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000208	0.00216	CbGpPWpGaD
Erythromycin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000208	0.00199	CcSEcCtD
Erythromycin—Vertigo—Methotrexate—multiple sclerosis	0.000205	0.00197	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CNR1—multiple sclerosis	0.000204	0.00212	CbGpPWpGaD
Erythromycin—Urticaria—Dexamethasone—multiple sclerosis	0.000204	0.00195	CcSEcCtD
Erythromycin—Urticaria—Betamethasone—multiple sclerosis	0.000204	0.00195	CcSEcCtD
Erythromycin—Dizziness—Prednisolone—multiple sclerosis	0.000203	0.00195	CcSEcCtD
Erythromycin—Abdominal pain—Betamethasone—multiple sclerosis	0.000203	0.00194	CcSEcCtD
Erythromycin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000203	0.00194	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CCR1—multiple sclerosis	0.000203	0.00211	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL13—multiple sclerosis	0.000203	0.00211	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000202	0.0021	CbGpPWpGaD
Erythromycin—Pruritus—Triamcinolone—multiple sclerosis	0.0002	0.00191	CcSEcCtD
Erythromycin—Pruritus—Methylprednisolone—multiple sclerosis	0.000199	0.00191	CcSEcCtD
Erythromycin—Convulsion—Methotrexate—multiple sclerosis	0.000198	0.0019	CcSEcCtD
Erythromycin—Chest pain—Methotrexate—multiple sclerosis	0.000195	0.00186	CcSEcCtD
Erythromycin—Decreased appetite—Prednisone—multiple sclerosis	0.000194	0.00186	CcSEcCtD
Erythromycin—Rash—Prednisolone—multiple sclerosis	0.000194	0.00186	CcSEcCtD
Erythromycin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000193	0.00185	CcSEcCtD
Erythromycin—Discomfort—Methotrexate—multiple sclerosis	0.000192	0.00184	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000189	0.00196	CbGpPWpGaD
Erythromycin—Confusional state—Methotrexate—multiple sclerosis	0.000188	0.0018	CcSEcCtD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000187	0.00194	CbGpPWpGaD
Erythromycin—Dizziness—Triamcinolone—multiple sclerosis	0.000187	0.00179	CcSEcCtD
Erythromycin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000187	0.00179	CcSEcCtD
Erythromycin—Dizziness—Methylprednisolone—multiple sclerosis	0.000186	0.00179	CcSEcCtD
Erythromycin—Feeling abnormal—Prednisone—multiple sclerosis	0.000184	0.00176	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000184	0.00191	CbGpPWpGaD
Erythromycin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000183	0.00175	CcSEcCtD
Erythromycin—Nausea—Prednisolone—multiple sclerosis	0.000183	0.00175	CcSEcCtD
Erythromycin—Pruritus—Betamethasone—multiple sclerosis	0.000181	0.00174	CcSEcCtD
Erythromycin—Pruritus—Dexamethasone—multiple sclerosis	0.000181	0.00174	CcSEcCtD
Erythromycin—Vomiting—Triamcinolone—multiple sclerosis	0.00018	0.00172	CcSEcCtD
Erythromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00018	0.00187	CbGpPWpGaD
Erythromycin—Vomiting—Methylprednisolone—multiple sclerosis	0.000179	0.00172	CcSEcCtD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000179	0.00186	CbGpPWpGaD
Erythromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000179	0.00186	CbGpPWpGaD
Erythromycin—Rash—Triamcinolone—multiple sclerosis	0.000178	0.00171	CcSEcCtD
Erythromycin—Anorexia—Methotrexate—multiple sclerosis	0.000178	0.0017	CcSEcCtD
Erythromycin—Rash—Methylprednisolone—multiple sclerosis	0.000178	0.0017	CcSEcCtD
Erythromycin—Urticaria—Prednisone—multiple sclerosis	0.000177	0.0017	CcSEcCtD
Erythromycin—Abdominal pain—Prednisone—multiple sclerosis	0.000177	0.00169	CcSEcCtD
Erythromycin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000175	0.00168	CcSEcCtD
Erythromycin—Diarrhoea—Betamethasone—multiple sclerosis	0.000175	0.00168	CcSEcCtD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000175	0.00182	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000174	0.00181	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000172	0.00179	CbGpPWpGaD
Erythromycin—Dizziness—Dexamethasone—multiple sclerosis	0.00017	0.00162	CcSEcCtD
Erythromycin—Dizziness—Betamethasone—multiple sclerosis	0.00017	0.00162	CcSEcCtD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000168	0.00175	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000168	0.00175	CbGpPWpGaD
Erythromycin—Nausea—Triamcinolone—multiple sclerosis	0.000168	0.00161	CcSEcCtD
Erythromycin—Nausea—Methylprednisolone—multiple sclerosis	0.000167	0.0016	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000167	0.00174	CbGpPWpGaD
Erythromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000165	0.00172	CbGpPWpGaD
Erythromycin—Hypersensitivity—Prednisone—multiple sclerosis	0.000165	0.00158	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000164	0.0017	CbGpPWpGaD
Erythromycin—Vomiting—Dexamethasone—multiple sclerosis	0.000163	0.00156	CcSEcCtD
Erythromycin—Vomiting—Betamethasone—multiple sclerosis	0.000163	0.00156	CcSEcCtD
Erythromycin—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000163	0.00169	CbGpPWpGaD
Erythromycin—Decreased appetite—Methotrexate—multiple sclerosis	0.000162	0.00155	CcSEcCtD
Erythromycin—Rash—Dexamethasone—multiple sclerosis	0.000162	0.00155	CcSEcCtD
Erythromycin—Rash—Betamethasone—multiple sclerosis	0.000162	0.00155	CcSEcCtD
Erythromycin—Pain—Methotrexate—multiple sclerosis	0.00016	0.00153	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000159	0.00165	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCL5—multiple sclerosis	0.000158	0.00164	CbGpPWpGaD
Erythromycin—Pruritus—Prednisone—multiple sclerosis	0.000158	0.00151	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000157	0.00163	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000155	0.00161	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000155	0.00161	CbGpPWpGaD
Erythromycin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000154	0.00147	CcSEcCtD
Erythromycin—Diarrhoea—Prednisone—multiple sclerosis	0.000153	0.00146	CcSEcCtD
Erythromycin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000153	0.00146	CcSEcCtD
Erythromycin—Nausea—Betamethasone—multiple sclerosis	0.000152	0.00146	CcSEcCtD
Erythromycin—Nausea—Dexamethasone—multiple sclerosis	0.000152	0.00146	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000152	0.00158	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000151	0.00157	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000151	0.00157	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000151	0.00157	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00015	0.00156	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00015	0.00156	CbGpPWpGaD
Erythromycin—Urticaria—Methotrexate—multiple sclerosis	0.000148	0.00142	CcSEcCtD
Erythromycin—Dizziness—Prednisone—multiple sclerosis	0.000148	0.00141	CcSEcCtD
Erythromycin—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000148	0.00153	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000148	0.00153	CbGpPWpGaD
Erythromycin—Abdominal pain—Methotrexate—multiple sclerosis	0.000148	0.00141	CcSEcCtD
Erythromycin—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000146	0.00151	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000145	0.00151	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL3—multiple sclerosis	0.000144	0.0015	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000143	0.00149	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCR5—multiple sclerosis	0.000142	0.00148	CbGpPWpGaD
Erythromycin—Vomiting—Prednisone—multiple sclerosis	0.000142	0.00136	CcSEcCtD
Erythromycin—Rash—Prednisone—multiple sclerosis	0.000141	0.00135	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—IL2RA—multiple sclerosis	0.00014	0.00146	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTGER4—multiple sclerosis	0.000139	0.00144	CbGpPWpGaD
Erythromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000138	0.00144	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000138	0.00143	CbGpPWpGaD
Erythromycin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000137	0.00132	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—PGR—multiple sclerosis	0.000137	0.00142	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCR3—multiple sclerosis	0.000134	0.0014	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CD28—multiple sclerosis	0.000133	0.00138	CbGpPWpGaD
Erythromycin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000133	0.00138	CbGpPWpGaD
Erythromycin—Nausea—Prednisone—multiple sclerosis	0.000133	0.00127	CcSEcCtD
Erythromycin—Pruritus—Methotrexate—multiple sclerosis	0.000132	0.00126	CcSEcCtD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000131	0.00136	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCR2—multiple sclerosis	0.000131	0.00136	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00013	0.00135	CbGpPWpGaD
Erythromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00013	0.00135	CbGpPWpGaD
Erythromycin—Diarrhoea—Methotrexate—multiple sclerosis	0.000128	0.00122	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000126	0.00131	CbGpPWpGaD
Erythromycin—Dizziness—Methotrexate—multiple sclerosis	0.000123	0.00118	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—POMC—multiple sclerosis	0.000123	0.00127	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000122	0.00127	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CNR1—multiple sclerosis	0.000121	0.00125	CbGpPWpGaD
Erythromycin—Vomiting—Methotrexate—multiple sclerosis	0.000119	0.00114	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000118	0.00122	CbGpPWpGaD
Erythromycin—Rash—Methotrexate—multiple sclerosis	0.000118	0.00113	CcSEcCtD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000117	0.00122	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000115	0.0012	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000115	0.0012	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000114	0.00118	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000114	0.00118	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000113	0.00118	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—POMC—multiple sclerosis	0.000111	0.00116	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000111	0.00116	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000111	0.00116	CbGpPWpGaD
Erythromycin—Nausea—Methotrexate—multiple sclerosis	0.000111	0.00106	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCL2—multiple sclerosis	0.000109	0.00113	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL10—multiple sclerosis	0.000109	0.00113	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000108	0.00112	CbGpPWpGaD
Erythromycin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000108	0.00112	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—SRM—multiple sclerosis	0.000106	0.0011	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000106	0.0011	CbGpPWpGaD
Erythromycin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000105	0.00109	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000103	0.00107	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	9.97e-05	0.00104	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	9.91e-05	0.00103	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—TYK2—multiple sclerosis	9.89e-05	0.00103	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	9.8e-05	0.00102	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—SRM—multiple sclerosis	9.56e-05	0.000994	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CD86—multiple sclerosis	9.49e-05	0.000986	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL5—multiple sclerosis	9.34e-05	0.000971	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.27e-05	0.000964	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.11e-05	0.000947	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL2—multiple sclerosis	9.06e-05	0.000942	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	8.95e-05	0.00093	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SPP1—multiple sclerosis	8.65e-05	0.000899	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8.65e-05	0.000899	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCR5—multiple sclerosis	8.42e-05	0.000875	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—SRM—multiple sclerosis	8.34e-05	0.000867	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL2RA—multiple sclerosis	8.29e-05	0.000862	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	8.27e-05	0.00086	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL2—multiple sclerosis	8.23e-05	0.000855	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.2e-05	0.000852	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	8.04e-05	0.000836	CbGpPWpGaD
Erythromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.82e-05	0.000813	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—POMC—multiple sclerosis	7.73e-05	0.000804	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—APOE—multiple sclerosis	7.66e-05	0.000796	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	7.49e-05	0.000778	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	7.49e-05	0.000778	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.36e-05	0.000765	CbGpPWpGaD
Erythromycin—ABCC1—Disease—GPC5—multiple sclerosis	7.36e-05	0.000765	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.32e-05	0.000761	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.18e-05	0.000746	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.16e-05	0.000744	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.15e-05	0.000743	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CD80—multiple sclerosis	6.92e-05	0.000719	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GPC5—multiple sclerosis	6.85e-05	0.000712	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP24A1—multiple sclerosis	6.74e-05	0.0007	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP27B1—multiple sclerosis	6.74e-05	0.0007	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.66e-05	0.000692	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.59e-05	0.000685	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—POMC—multiple sclerosis	6.58e-05	0.000684	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.54e-05	0.000679	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.45e-05	0.000671	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL2—multiple sclerosis	6.44e-05	0.000669	CbGpPWpGaD
Erythromycin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.34e-05	0.000659	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—MAPK1—multiple sclerosis	6.3e-05	0.000654	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SRM—multiple sclerosis	6.17e-05	0.000641	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GPC5—multiple sclerosis	6.16e-05	0.000641	CbGpPWpGaD
Erythromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.03e-05	0.000627	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SRM—multiple sclerosis	6.03e-05	0.000627	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	5.88e-05	0.000611	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	5.88e-05	0.000611	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TYK2—multiple sclerosis	5.84e-05	0.000607	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.83e-05	0.000606	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.81e-05	0.000604	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.75e-05	0.000597	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.75e-05	0.000597	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.75e-05	0.000597	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—POMC—multiple sclerosis	5.72e-05	0.000594	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—RRM1—multiple sclerosis	5.68e-05	0.00059	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.59e-05	0.000581	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	5.59e-05	0.000581	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.58e-05	0.00058	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.58e-05	0.00058	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.47e-05	0.000568	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GPC5—multiple sclerosis	5.38e-05	0.000559	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.21e-05	0.000541	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.21e-05	0.000541	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—RRM1—multiple sclerosis	5.11e-05	0.000531	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.92e-05	0.000511	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.89e-05	0.000508	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL2—multiple sclerosis	4.86e-05	0.000505	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL6—multiple sclerosis	4.84e-05	0.000503	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RPL5—multiple sclerosis	4.79e-05	0.000497	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MMP9—multiple sclerosis	4.6e-05	0.000478	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SLC11A1—multiple sclerosis	4.58e-05	0.000476	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SRM—multiple sclerosis	4.55e-05	0.000473	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.53e-05	0.000471	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—RRM1—multiple sclerosis	4.45e-05	0.000463	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.41e-05	0.000458	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.4e-05	0.000458	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.39e-05	0.000457	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	4.35e-05	0.000452	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	4.35e-05	0.000452	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.25e-05	0.000442	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.25e-05	0.000442	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.23e-05	0.00044	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STAT3—multiple sclerosis	4.09e-05	0.000425	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.98e-05	0.000413	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.96e-05	0.000412	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.9e-05	0.000405	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.89e-05	0.000404	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MYC—multiple sclerosis	3.8e-05	0.000395	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TGFB1—multiple sclerosis	3.79e-05	0.000394	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.78e-05	0.000393	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MAPK1—multiple sclerosis	3.72e-05	0.000387	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD28—multiple sclerosis	3.66e-05	0.00038	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SRM—multiple sclerosis	3.63e-05	0.000378	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.45e-05	0.000358	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.4e-05	0.000354	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.37e-05	0.00035	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.29e-05	0.000342	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.28e-05	0.000341	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—BCHE—multiple sclerosis	3.26e-05	0.000339	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.22e-05	0.000335	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.21e-05	0.000333	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.21e-05	0.000333	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.1e-05	0.000323	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.95e-05	0.000307	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—BCHE—multiple sclerosis	2.93e-05	0.000305	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GPC5—multiple sclerosis	2.93e-05	0.000305	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL6—multiple sclerosis	2.86e-05	0.000297	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SRM—multiple sclerosis	2.8e-05	0.000291	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD86—multiple sclerosis	2.61e-05	0.000271	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.6e-05	0.00027	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.56e-05	0.000266	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.56e-05	0.000266	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.56e-05	0.000266	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.5e-05	0.00026	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—RRM1—multiple sclerosis	2.43e-05	0.000253	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.34e-05	0.000243	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CCR5—multiple sclerosis	2.32e-05	0.000241	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HLA-A—multiple sclerosis	2.26e-05	0.000235	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.24e-05	0.000233	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.24e-05	0.000232	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.19e-05	0.000228	CbGpPWpGaD
Erythromycin—ABCC1—Disease—APOE—multiple sclerosis	2.11e-05	0.000219	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.09e-05	0.000217	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.98e-05	0.000205	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.98e-05	0.000205	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.96e-05	0.000204	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.94e-05	0.000202	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD80—multiple sclerosis	1.91e-05	0.000198	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.89e-05	0.000197	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.85e-05	0.000192	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.81e-05	0.000188	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—APOE—multiple sclerosis	1.76e-05	0.000183	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—POMC—multiple sclerosis	1.68e-05	0.000175	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TYK2—multiple sclerosis	1.61e-05	0.000167	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—APOE—multiple sclerosis	1.54e-05	0.00016	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ALB—multiple sclerosis	1.54e-05	0.00016	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—POMC—multiple sclerosis	1.52e-05	0.000158	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.5e-05	0.000156	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.5e-05	0.000156	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD4—multiple sclerosis	1.45e-05	0.000151	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.4e-05	0.000146	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—BCHE—multiple sclerosis	1.4e-05	0.000145	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ALB—multiple sclerosis	1.38e-05	0.000144	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—POMC—multiple sclerosis	1.32e-05	0.000137	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.29e-05	0.000134	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALB—multiple sclerosis	1.21e-05	0.000125	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.18e-05	0.000122	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000118	CbGpPWpGaD
Erythromycin—ABCC1—Disease—STAT3—multiple sclerosis	1.13e-05	0.000117	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.11e-05	0.000116	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—APOE—multiple sclerosis	1.11e-05	0.000116	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MYC—multiple sclerosis	1.05e-05	0.000109	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TGFB1—multiple sclerosis	1.04e-05	0.000108	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MAPK1—multiple sclerosis	1.02e-05	0.000106	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—POMC—multiple sclerosis	9.78e-06	0.000102	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—POMC—multiple sclerosis	9.56e-06	9.93e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALB—multiple sclerosis	8.91e-06	9.26e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALB—multiple sclerosis	8.71e-06	9.06e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.6e-06	8.94e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—APOE—multiple sclerosis	8.39e-06	8.73e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IL6—multiple sclerosis	7.87e-06	8.17e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—POMC—multiple sclerosis	7.21e-06	7.5e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—APOE—multiple sclerosis	6.7e-06	6.97e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALB—multiple sclerosis	6.57e-06	6.83e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—POMC—multiple sclerosis	5.76e-06	5.98e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALB—multiple sclerosis	5.25e-06	5.46e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—APOE—multiple sclerosis	5.17e-06	5.38e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—POMC—multiple sclerosis	4.44e-06	4.62e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALB—multiple sclerosis	4.05e-06	4.21e-05	CbGpPWpGaD
